Research for the Improvement in Measurement Methods and the Effect of Sodium Intake on Cardiovascular Health

NCT ID: NCT01438619

Last Updated: 2013-01-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

620 participants

Study Classification

OBSERVATIONAL

Study Start Date

2011-04-30

Study Completion Date

2011-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Epidemiological, clinical and animal-experimental evidence shows a direct relationship between dietary sodium intake, blood pressure and cardiovascular event. Diverse questionnaire and 24 hour urinary sodium measurement are used to estimate sodium intake. Complete reflection of eating and cooking habits to the dietary survey method is difficult. Furthermore, the differences of database between countries make it difficult to compare the amount of sodium intake between countries. It is also difficult to consider individual variation of cooking and eating habits. Due to limitations of dietary survey method, WHO recommended 24 hour urinary sodium measurement to estimated sodium intake in the population survey, and many countries are adopting. However, in Korea National Health and Nutrition Examination Survey, only dietary survey method has been used.

The present survey study was designed 1) to test the feasibility of 24 hour urinary sodium measurement for the estimation of sodium intake (including percentage of complete 24 hour urine sample collection) in the population based study; 2) to establish feasible method of 24 hour urinary sodium measurement; 3) to compare 24 hour urinary sodium measurement to the dietary survey method; and 4) to estimate the sodium intake by 24 hour urinary sodium measurement in Goyang city general population (aged 20-70 years).

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Measurements: should be performed for 2 days

1. 24 hour urine Na, K and Creatinine, 24 hour urine amount

1. Calculation of urine completeness index : Creatinine/(21 x Bwt)
2. Definition of incomplete urine collection: complete index less than 0.7 and loss of urine more than one time or 100 mL
2. 24 hour ambulatory blood pressure

1. mobile-O-graph (IEM GmbH)
2. measurement interval: 30 minutes
3. Measurement of peripheral blood pressure : microlife WatchBP office

1. Sitting position
2. After 5 minutes resting
3. Peripheral systolic BP (pSBP), Peripheral diastolic BP (pDBP),
4. Central aortic blood pressure

1. SphygmoCor (AtCor Medical, Australia)
2. Central systolic blood pressure
5. Pulse wave velocity

1. VP2000 (Colin, Japan)
2. pulse wave velocity (PWV): carotid-femoral Pulse Wave Velocity, heart-femoral Pulse Wave Velocity and brachial-ankle Pulse Wave Velocity
3. distance measured by tape: distance from suprasternal notch to carotid artery, distance from suprasternal notch to femoral artery
4. Silent environment
6. Electrocardiography
7. Blood chemistry and complete blood count

1. Measure at the morning of first day after overnight fasting
2. complete blood count, blood urea nitrogen/Creatinine, Fasting blood glucose, Total cholesterol, triglyceride, HDL cholesterol

Measurement protocol

1. 1st day

1. Visit hospital before 9:00 AM after overnight fasting
2. Sampling of venous blood
3. start 24 hour urine collection from 9:00 AM (with education for complete collection)
4. start 24 hour ambulatory blood pressure monitoring, in parallel with 24 hour urine collection
2. 2nd day

1. Measure central aortic blood pressure
2. Measure Pulse Wave Velocity
3. Electrocardiography

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Sodium Intake General Population

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

ECOLOGIC_OR_COMMUNITY

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

representitives of Goyang city

1. Representative population of Goyang city who were randomly selected by digit dialing (RDD) method
2. Volunteers who are reside in Goyang city

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* General population who are reside in Goyang city

Exclusion Criteria

* Urinary tract disease
* Known chronic kidney disease
* Unable to measure 24 hour ambulatory blood pressure measurement
* Unable to collect 24 hour urine sample
* Pregnancy
* Alcoholics
* Severe liver disease
* Night workers
* Mental retardation
Minimum Eligible Age

20 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ministry of Food and Drug Safety, Korea

OTHER_GOV

Sponsor Role collaborator

DongGuk University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Moo-Yong Rhee

Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Moo-Yong Rhee, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Clinical Trial Center, Dongguk University Ilsan Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinical Trial Center, Dongguk University Ilsan Hospital

Goyang-si, Gyeonggi-do, South Korea

Site Status

Countries

Review the countries where the study has at least one active or historical site.

South Korea

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

11162KFDA162

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

11162KFDA162

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Sodium Sensitivity in African Americans
NCT00000536 COMPLETED PHASE2
Cheese Consumption and Human Microvascular Function
NCT03376555 COMPLETED PHASE1/PHASE2